.jpg "Yanting Wu, PharmD photo")
T32 Postdoc Fellow
Division of Clinical Pharmacology, Indiana University School of Medicine
Dr. Yanting Wu is an NIH T32 Clinical Pharmacology Fellow at Indiana University School of Medicine, mentored by Dr. Zeruesenay Desta. Her research focuses on pharmacogenomics, drug-drug interactions, and precision medicine, with an emphasis on optimizing drug therapies through translational research. Her work aims to bridge genetic variability and clinical outcomes, particularly in drug metabolism and pharmacokinetics.
Yanting holds a PharmD from Western University of Health Sciences, where she graduated with distinction, and a Bachelor’s degree in chemistry from UCLA, earning departmental honors. Her scientific foundation in chemistry and pharmacy underpins her clinical pharmacology research.
As a fellow, Yanting leads high-impact projects, including the influence of pharmacogenetics and other potential factors on voriconazole metabolism, the role of CYP2B6 genotype in the interactions between efavirenz, methadone, and tizanidine, and the development of ultra-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) assays for precise drug quantification. Additionally, she explores pharmacogenomic factors influencing tacrolimus dosing in transplant recipients, with the goal of optimizing therapeutic outcomes and advancing precision medicine in clinical practice.
Yanting has also contributed to digital health and pharmacy informatics, exploring AI applications in medication therapy management and blockchain frameworks for healthcare data access. Her interdisciplinary research integrates innovative technologies to address health disparities and improve patient care.
Yanting is committed to advancing clinical pharmacology through research that improves patient care and therapeutic outcomes.